Genesis Biotechnology LLC is categorized under Commercial Biotechnical Research in Scottsdale, AZ and active since 2009.
Genesis Biotechnology LLC was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Jemmy Sutando at the company’s single location by writing to 8868 East Rimrock Drive, Scottsdale, Arizona AZ 85255 or by phoning (404) 509-5355. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Genesis Biotechnology LLC |
Contact Person: | Jemmy Sutando |
Address: | 8868 East Rimrock Drive, Scottsdale, Arizona 85255 |
Phone Number: | (404) 509-5355 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Genesis Biotechnology LLC was started in 2009 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Jemmy Sutando for inquiries that concern Genesis Biotechnology LLC by calling the company number (404) 509-5355, as your correspondence is most welcome. Additionally, the physical location of the single location of Genesis Biotechnology LLC can be found at the coordinates 33.663456,-111.886905 as well as the street address 8868 East Rimrock Drive in Scottsdale, Arizona 85255.
For its online presence, you may visit Genesis Biotechnology LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.